吸入式一氧化氮（iNO）輸送系統市場：按應用、最終用戶、技術、輸送裝置類型、分銷管道和輸送方式分類－全球預測，2025-2032年

預計到 2032 年，吸入式一氧化氮 (iNO) 輸送系統市場將成長至 6.8,118 億美元，複合年成長率為 10.21%。

對吸入式一氧化氮（iNO）輸送系統的全面介紹，重點闡述了其在現代醫療保健環境中的臨床效用、技術進步和採購重點。

吸入式一氧化氮（iNO）輸送系統處於急性呼吸護理、心胸支持和新生兒重症監護的關鍵交匯點，可在傳統治療方法不足時提供靶向肺血管擴張。這些系統已從集中式氣瓶發展到配備整合監測功能的先進電子發生器，從而實現了更精確的劑量控制、更高的安全性以及更廣泛的應用場景，包括門診和家庭醫療保健環境。臨床醫生、醫院管理者和設備製造商正在應對一個由臨床證據、技術創新和不斷發展的醫療服務模式共同塑造的局面，這些模式強調便攜性、安全性和易用性。

相關人員正在摒棄傳統的醫療實踐模式，日益關注在控制整體醫療成本的同時最佳化病患療效。這需要對成人、新生兒和兒童人群的具體應用需求以及整合系統與獨立設備的相對優勢有深入的了解。隨著醫療系統優先考慮醫療服務的連續性和縮短住院時間，能夠促進患者從醫院安全過渡到家庭或門診護理的交付平台正日益受到重視。因此，採購決策需要在臨床療效、操作流程相容性和供應鏈彈性之間取得平衡，從而推動採購人員和臨床領導者採用新一輪的評估標準。

臨床創新、醫療服務分散化以及實證醫學的期望正在迅速改變吸入式一氧化氮 (iNO) 解決方案的競爭格局和營運格局。

吸入式一氧化氮療法的格局正在經歷一場變革，其驅動力來自臨床需求、技術創新和不斷變化的醫療服務模式。電子發生器設計的進步正在改變人們對便攜性、自動化監測和與電子健康記錄系統整合等方面的期望，從而拓展了其在加護病房以外的潛在應用場景。同時，劑量精確度和警報系統的改進提高了安全性標準，促使臨床團隊重新評估傳統的禁忌症，並探索針對特定呼吸系統和心臟疾病的早期介入策略。

同時，醫療服務的去中心化趨勢正在加速推動對適用於門診中心、家庭醫療保健和診所計畫的設備的關注。這一趨勢的驅動力源自於人們日益重視縮短住院時間和降低再入院率，促使決策者轉向能夠實現安全過渡照護的設備。另一個顯著的變化是整合系統的成熟，這些系統將輸送、監測和供應管理整合到單一的解決方案中，對僅專注於氣瓶的獨立設備和供應商的地位構成了挑戰。最後，監管機構的審查以及支付方對證明實際臨床和經濟價值的關注，正促使製造商大力投資於上市後證據的生成、結果研究和互通性，從而創造一個更加以證據主導的商業化環境。

美國關稅對醫療設備採購、分銷和購買行為在2025年產生的多方面營運和供應鏈影響

關稅等政策措施會對吸入式一氧化氮（iNO）生態系統產生連鎖反應，改變零件成本結構、進口動態和供應商議價能力，而未必會改變其臨床應用基礎。當關稅推高進口產生器、氣瓶和電子元件的國內價格時，由於買家要求更長的前置作業時間和更明確的供應保證，製造商往往會重新評估籌資策略。

關稅主導的成本壓力也將影響分銷策略。經銷商和直銷管道可能會重新評估庫存政策和定價模式以保障淨利率，這會導致某些醫院採購模式出現暫時的供應限制。同時，不斷上漲的投入成本往往會加速採用能夠減少重複性支出的技術，例如減少氣瓶消費量的電子發生器和能夠實現間歇給藥的系統。從監管和合約角度來看，公共和私人採購方可能會要求提高組件來源的透明度，作為風險評估的一部分，合約條款也可能擴大包含有關關稅轉嫁和供應中斷應急措施的條款。綜上所述，這些動態凸顯了積極主動的供應鏈風險管理和情境規劃對於維持臨床用藥連續性的重要性。

詳細的細分情報揭示了應用、最終用戶、技術、設備類型、通路和交付模式如何塑造差異化的臨床和商業策略。

細分分析揭示了應用、最終用戶、技術、給藥裝置類型、分銷管道和給藥方式等方面的臨床、營運和商業考慮。應用領域包括成人族群，心臟手術中的低氧血症和肺動脈高壓代表不同的臨床路徑，需要不同的給藥策略和監測強度；以及新生兒族群，新生兒低氧性呼吸衰竭和持續性肺動脈高壓需要靈敏的控制和嚴格的安全措施。最終用戶包括優先考慮吞吐量和易於設置的門診中心和診所、重視便攜性和看護者培訓的家庭醫療保健項目，以及將與重症加護系統的整合和互通性視為重中之重的醫院。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

• 在新生兒和成人加護治療中採用攜帶式和穿戴式式吸入一氧化氮（iNO）輸送裝置
• 整合人工智慧驅動的給藥演算法，以最佳化吸入一氧化氮 (iNO) 的劑量和臨床療效
• 將吸入一氧化氮 (iNO) 療法的應用範圍從新生兒護理擴展到成人肺動脈高壓的治療。
• 感測器技術的進步使得即時監測吸入的一氧化氮（iNO）和高鐵血紅蛋白水平成為可能。
• 早期出院通訊協定後，對居家吸入一氧化氮（iNO）療法的需求日益成長
• 醫療設備製造商與製藥公司在氧化氮聯合治療的合作
• 新興市場下一代吸入式一氧化氮（iNO）系統的監管核准和快速審查途徑
• 開發環保一氧化氮發生技術，以減少對化學氣瓶的依賴

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 吸入式一氧化氮 (iNO) 輸送系統市場（按應用分類）

• 成人
  • 心血管手術期間的低氧血症
  • 肺動脈高壓
• 新生
  • 低氧性呼吸衰竭
  • 新生兒持續性肺動脈高壓
• 孩子們

9. 吸入式一氧化氮（iNO）輸送系統市場（依最終用戶分類）

• 門診治療中心
• 診所
• 居家醫療
• 醫院

10. 吸入式一氧化氮 (iNO) 輸送系統市場（以技術分類）

• 鋼瓶氣體
• 電子發電機
  • 固定的
  • 可攜式的

11. 吸入式一氧化氮 (iNO) 輸送系統市場（依輸送裝置類型分類）

• 整合系統
• 獨立版

12. 吸入式一氧化氮 (iNO) 輸送系統市場（依通路分類）

• 直銷
• 經銷商
• 線上管道

13. 吸入式一氧化氮 (iNO) 輸送系統市場（以輸送方式分類）

• 連續的
• 間歇性的

14. 吸入式一氧化氮 (iNO) 輸送系統市場（按地區分類）

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

15. 吸入式一氧化氮 (iNO) 輸送系統市場（依組別分類）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

16. 各國吸入式一氧化氮（iNO）輸送系統市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第17章 競爭格局

• 2024年市佔率分析
• FPNV定位矩陣，2024
• 競爭分析
  • Linde plc
  • Air Liquide SA
  • Air Products and Chemicals, Inc.
  • Messer Group GmbH
  • Taiyo Nippon Sanso Corporation
  • Air Water Inc.
  • Bellerophon Therapeutics, Inc.

The Inhaled Nitric Oxide Delivery Systems Market is projected to grow by USD 681.18 million at a CAGR of 10.21% by 2032.

A comprehensive introduction to inhaled nitric oxide delivery systems that frames clinical utility, technological evolution, and procurement priorities for modern care settings

Inhaled nitric oxide delivery systems occupy a critical intersection between acute respiratory care, cardiothoracic support, and neonatal intensive care, offering targeted pulmonary vasodilation when conventional therapies are inadequate. These systems have evolved from centralized gas cylinders to advanced electronic generators with integrated monitoring, enabling more precise dosing, improved safety, and broader settings of use, including ambulatory care and home healthcare environments. Clinicians, hospital administrators, and device manufacturers are navigating a landscape shaped by clinical evidence, technological innovation, and evolving care delivery models that place a premium on portability, safety, and ease of use.

Transitioning from historical practice patterns, stakeholders are increasingly focused on optimizing patient outcomes while managing total cost of care. This requires a nuanced understanding of application-specific needs across adult, neonatal, and pediatric populations, as well as the comparative advantages of integrated systems versus standalone devices. As health systems emphasize continuity of care and shorter inpatient stays, delivery platforms that facilitate safe transition from hospital to home or outpatient settings are gaining strategic interest. Consequently, procurement decisions now balance clinical efficacy, operational workflow compatibility, and supply chain resilience, propelling a new wave of evaluation criteria among purchasers and clinical leaders.

How clinical innovation, decentralization of care, and evidence expectations are rapidly reshaping the competitive and operational landscape for inhaled nitric oxide solutions

The landscape for inhaled nitric oxide delivery is undergoing transformative shifts driven by convergence of clinical demand, technological innovation, and changes in care delivery models. Advances in electronic generator design have shifted expectations around portability, automated monitoring, and integration with electronic health records, thereby expanding potential use cases beyond the intensive care unit. Simultaneously, improvements in dosing precision and alarm systems have elevated safety benchmarks, prompting clinical teams to reassess traditional contraindications and explore earlier intervention strategies in select respiratory and cardiac contexts.

Concurrently, care decentralization is accelerating interest in devices suitable for ambulatory centers, home healthcare, and clinic-based programs. This movement is supported by growing emphasis on reducing hospital length of stay and readmission rates, which reorients decision-making toward devices that enable safe step-down care. Another notable shift is the maturation of integrated systems that combine delivery, monitoring, and supply management into single solutions, challenging the role of standalone devices and suppliers focused solely on gas cylinders. Finally, regulatory scrutiny and payer interest in demonstrating real-world clinical and economic value are prompting manufacturers to invest heavily in post-market evidence generation, outcomes research, and interoperability, creating a more evidence-driven commercialization environment.

Assessing the multifaceted operational and supply chain effects that United States tariff measures can exert on device sourcing, distribution, and procurement practices in 2025

Policy actions such as tariffs can reverberate across the inhaled nitric oxide ecosystem by altering component cost structures, import dynamics, and supplier bargaining power without necessarily changing the clinical rationale for use. When tariffs increase the landed cost of imported generators, cylinders, or electronic components, manufacturers often reassess sourcing strategies, which may include reshoring elements of production, diversifying supplier bases, or redesigning products to reduce dependence on tariff-exposed parts. These supply-side adaptations have downstream effects on procurement timelines and contract negotiations, as buyers seek longer lead times and clearer supply assurances.

Tariff-driven cost pressures also influence distribution strategies. Distributors and direct sales channels may recalibrate inventory policies and pricing models to preserve margins, which can temporarily constrain availability for certain hospital purchasing patterns. In parallel, higher input costs tend to accelerate adoption of technologies that reduce recurring expenditures, such as electronic generators that lower cylinder consumption or systems that enable intermittent dosing. From a regulatory and contracting perspective, public and private purchasers may seek greater transparency in origin of components as part of risk assessments, and contractual terms may increasingly include clauses addressing tariff pass-throughs or supply disruption contingencies. Collectively, these dynamics underscore the importance of proactive supply chain risk management and scenario planning to maintain continuity in clinical access.

Deep segmentation intelligence revealing how application, end user, technology, device type, channel, and delivery mode shape differentiated clinical and commercial strategies

Segmentation analysis reveals distinct clinical, operational, and commercial imperatives across application, end user, technology, delivery device type, distribution channel, and mode of delivery. Based on Application, market study spans Adult populations-where Hypoxemia in Cardiac Surgery and Pulmonary Hypertension represent divergent clinical pathways requiring different dosing strategies and monitoring intensity-as well as Neonatal populations where Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension of the Newborn demand highly sensitive control and rigorous safety features; Pediatric patients bridge these domains and often require devices adaptable to size and dosing complexity. Based on End User, the spectrum includes Ambulatory Care Centers and Clinics that prioritize throughput and ease of setup, Home Healthcare programs that emphasize portability and caregiver training, and Hospitals where integration with critical care systems and interoperability are paramount.

Based on Technology, options range from Cylinder Gas systems, which are familiar and widely deployed for their simplicity, to Electronic Generators that offer programmable dosing and reduced cylinder dependency; among Electronic Generators, distinctions between Fixed and Portable units drive placement decisions and influence procurement criteria. Based on Delivery Device Type, Integrated Systems that combine delivery and monitoring challenge traditional procurement processes, while Standalone devices can be attractive for modular deployments and retrofit scenarios. Based on Distribution Channel, Direct Sales arrangements support clinical training and contracting, Distributors can expand geographic reach and inventory support, and Online Channels provide a complementary route for ancillary products and consumables. Finally, based on Mode Of Delivery, Continuous therapies prioritize stability and long-term management capabilities, whereas Intermittent delivery requires robust titration features and rapid response monitoring. Together, these segmentation lenses inform tailored commercial strategies, clinical training requirements, and product roadmaps, underscoring that a one-size-fits-all approach is unlikely to meet the nuanced needs of diverse stakeholders.

Regional market dynamics and clinical adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access, procurement, and commercialization

Regional dynamics materially influence clinical adoption patterns, reimbursement approaches, and the strategic priorities of manufacturers and distributors. In the Americas, strong academic medical centers and a concentration of cardiothoracic and neonatal specialty programs create focal points for early clinical adoption and real-world evidence generation, and procurement cycles often reflect integrated value assessments and negotiations with large health systems. As a result, there is heightened attention to device interoperability, service support models, and contractual terms that enable long-term clinical studies.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, hospital procurement structures, and payer models vary widely across countries. In many European markets, centralized health technology assessment bodies and regional procurement consortia shape adoption decisions and require robust clinical and economic evidence. In parts of the Middle East and Africa, investment in tertiary care capacity is expanding, creating opportunities for suppliers that can provide comprehensive training and lifecycle support. Market entrants in this region commonly prioritize adaptable service models and locally compliant installation and maintenance capabilities.

Asia-Pacific exhibits rapid infrastructural growth in critical and neonatal care, coupled with an emphasis on domestic manufacturing in several countries. This combination yields a dual strategy for international suppliers: partnering with local manufacturers to navigate regulatory and procurement pathways, and offering differentiated products that address the demand for portable and easy-to-use devices in both urban tertiary centers and decentralized care settings. Across all regions, supply chain resilience, regulatory alignment, and evidence of clinical benefit remain core considerations in planning market access and commercial operations.

How leading manufacturers and service providers are differentiating through safety, evidence generation, and adaptable commercial models to secure clinical adoption

Leading companies active in the inhaled nitric oxide delivery space are investing across multiple fronts: engineering for safety and usability, building evidence packages that demonstrate clinical differentiation, and expanding service portfolios to support long-term device uptime. Technology leaders emphasize integration of monitoring, alarms, and interoperability with hospital information systems to reduce clinician burden and enable safer titration protocols. Competitors focused on gas-cylinder solutions maintain relevance by optimizing supply logistics and providing robust support networks for institutions where electronic generators have not yet achieved broad uptake.

Strategic behaviors include pursuing partnerships with clinical research networks to accelerate post-market surveillance and outcomes data, forming distribution alliances to broaden geographic reach, and pursuing modular product strategies that allow incremental upgrades without large capital replacement. Companies that excel in training and clinician engagement gain traction in neonatal and pediatric settings where operator familiarity and safety culture are critical. Meanwhile, firms that adopt flexible commercial models-leasing, managed services, and bundled consumable programs-strengthen relationships with health systems seeking predictable operating expenses. The competitive landscape is therefore characterized by a blend of technological differentiation, evidence generation, and service-oriented commercial models, each of which contributes to long-term adoption and customer retention.

Actionable strategic initiatives that industry leaders can implement to accelerate uptake, build resilience, and demonstrate clinical and economic value in complex healthcare systems

Industry leaders should prioritize a set of actionable initiatives to strengthen market position, enhance clinical impact, and reduce operational risk. First, invest in robust post-market evidence programs that measure not only physiological endpoints but also operational outcomes such as length of stay, readmission, and caregiver burden; these data will support reimbursement discussions and hospital procurement decisions. Second, develop flexible commercial models that align with customer preferences, including options for capital leasing, managed services, and outcomes-linked agreements that distribute risk and incentivize long-term partnerships. Third, enhance device interoperability and digital integration to reduce clinician workload and facilitate data capture for quality improvement initiatives.

In parallel, supply chain diversification is essential: map critical components, qualify alternative suppliers, and consider localized manufacturing or assembly to mitigate tariff exposure and logistical disruption. Strengthen training and credentialing programs targeted at neonatal and pediatric teams, as these areas are particularly sensitive to operator expertise and safety culture. Finally, collaborate with payers, hospital procurement groups, and clinical thought leaders to develop value narratives that articulate both clinical benefit and economic rationale, thereby smoothing pathways to adoption across varied care settings and geographies.

A rigorous mixed-methods research methodology blending primary clinical interviews, device technical analysis, and regulatory review to ensure balanced, actionable insights

This research employs a mixed-methods approach combining qualitative expert interviews, device specification analysis, regulatory literature review, and synthesis of peer-reviewed clinical evidence to produce an integrated view of the inhaled nitric oxide delivery landscape. Primary insights were derived from structured interviews with clinicians across neonatal, pediatric, and adult cardiopulmonary specialties, procurement leaders at acute and ambulatory care institutions, and senior executives at device manufacturers and distributors. These perspectives were triangulated with device technical documentation and regulatory filings to assess safety features, interoperability capabilities, and device classifications across jurisdictions.

Secondary analysis incorporated systematic review of clinical studies, guidelines, and consensus statements to contextualize application-specific requirements and safety considerations. Supply chain and commercial dynamics were evaluated through examination of public procurement frameworks, industry reports, and case studies of recent product launches and market entry strategies. Throughout the methodology, emphasis was placed on corroborating claims through multiple independent sources and prioritizing primary clinical input where discrepancies arose, ensuring that conclusions reflect a balanced synthesis of clinical relevance, technological capability, and operational feasibility.

Concluding synthesis that ties together clinical imperatives, technological trends, and organizational strategies to guide adoption and long-term planning

Inhaled nitric oxide delivery systems are positioned at an inflection point where clinical need, technology maturation, and shifting care delivery models intersect. The device landscape will continue to be shaped by demands for improved safety, greater portability, and demonstrable outcomes that justify broader use across ambulatory and home settings as well as traditional hospital environments. Manufacturers and suppliers that align product development with the operational realities of neonatal and adult critical care, while simultaneously investing in evidence generation and supply chain resilience, will be best placed to capture sustained clinical adoption.

For clinical leaders and procurement professionals, the imperative is to evaluate devices not only on immediate performance metrics but also on integration potential, training requirements, and lifecycle service commitments. Forward-looking strategies that combine technological differentiation, flexible commercial models, and proactive risk mitigation will enable organizations to deliver better patient outcomes at manageable total cost of care. Ultimately, the convergence of these elements will determine which technologies become standard of care across diverse clinical settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Adoption of portable and wearable inhaled nitric oxide delivery devices for neonatal and adult critical care
• 5.2. Integration of AI-driven dosing algorithms to optimize inhaled nitric oxide delivery and clinical outcomes
• 5.3. Expansion of inhaled nitric oxide therapy into adult pulmonary hypertension treatment beyond neonatal care
• 5.4. Advances in sensor technology enabling real-time monitoring of inhaled nitric oxide and methemoglobin levels
• 5.5. Rising demand for home-based inhaled nitric oxide therapy following early hospital discharge protocols
• 5.6. Collaboration between medical device manufacturers and pharmaceutical firms for combination nitric oxide therapies
• 5.7. Regulatory approvals and expedited review pathways for next-generation inhaled nitric oxide systems in emerging markets
• 5.8. Development of eco-friendly nitric oxide generation technologies reducing reliance on chemical gas cylinders

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Inhaled Nitric Oxide Delivery Systems Market, by Application

• 8.1. Adult
  • 8.1.1. Hypoxemia In Cardiac Surgery
  • 8.1.2. Pulmonary Hypertension
• 8.2. Neonatal
  • 8.2.1. Hypoxemic Respiratory Failure
  • 8.2.2. Persistent Pulmonary Hypertension Of The Newborn
• 8.3. Pediatric

9. Inhaled Nitric Oxide Delivery Systems Market, by End User

• 9.1. Ambulatory Care Centers
• 9.2. Clinics
• 9.3. Home Healthcare
• 9.4. Hospitals

10. Inhaled Nitric Oxide Delivery Systems Market, by Technology

• 10.1. Cylinder Gas
• 10.2. Electronic Generator
  • 10.2.1. Fixed
  • 10.2.2. Portable

11. Inhaled Nitric Oxide Delivery Systems Market, by Delivery Device Type

• 11.1. Integrated Systems
• 11.2. Standalone

12. Inhaled Nitric Oxide Delivery Systems Market, by Distribution Channel

• 12.1. Direct Sales
• 12.2. Distributors
• 12.3. Online Channels

13. Inhaled Nitric Oxide Delivery Systems Market, by Mode Of Delivery

• 13.1. Continuous
• 13.2. Intermittent

14. Inhaled Nitric Oxide Delivery Systems Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Inhaled Nitric Oxide Delivery Systems Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Inhaled Nitric Oxide Delivery Systems Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Linde plc
  • 17.3.2. Air Liquide S.A.
  • 17.3.3. Air Products and Chemicals, Inc.
  • 17.3.4. Messer Group GmbH
  • 17.3.5. Taiyo Nippon Sanso Corporation
  • 17.3.6. Air Water Inc.
  • 17.3.7. Bellerophon Therapeutics, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 32. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 158. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 159. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 160. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 161. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 162. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 167. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 168. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 169. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 170. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 171. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 172. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 173. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 174. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 175. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 176. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 177. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 180. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 181. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 182. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 185. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 186. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 187. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 188. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 189. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 190. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 191. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 192. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 193. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 194. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 195. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 196. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 197. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 200. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 201. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 202. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 203. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 204. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 205. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 206. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 207. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 208. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 209. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 210. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 211. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 212. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 213. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 214. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 215. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 216. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 239. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 240. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 241. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 242. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 243. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 244. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 245. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 246. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 247. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 248. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
• TABLE 257. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 260. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 261. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
• TABLE 262. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
• TABLE 263. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
• TABLE 264. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
• TABLE 265. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 266. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 267. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 268. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 269. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
• TABLE 270. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
• TABLE 271. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 273. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 274. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 275. MIDDLE EAST INHALED NITRIC OXID